XBI continues to strengthen following a multi-month breakout, with bullish trend signals supporting upside targets near key Fibonacci retracement resistance levels.
Real-time index price for Nasdaq Biotechnology Index (NBI), along with buy or sell indicators, analysis, charts, historical ...
It has been known for years by insiders as the “hidden gem” of North Carolina’s life sciences ecosystem. And now, after four ...
Consumer365 has named Domain.com as an affordable domain provider for startups in 2026 based on pricing clarity, entry-level access, and bundled tools that support early website setup. The assessment ...
All Penny Stocks (English) on MSN
Biotech surges as big money backs high-stakes kidney disease push
The immune system has become one of biotech's most important battlegrounds as drug developers race to target inflammatory ...
Krystal Biotech leverages its HSV-1 gene delivery platform, with VYJUVEK generating strong cash flow. Read why I rate KRYS ...
Sara Ahmed ’26, a student in the MBA for Executives program, drew on her background in biotech to craft a speaker series ...
Discover the role of biotechnology in healthcare, medicine, and investment. Understand biotech processes, top companies, and ...
Altitude Labs, an offshoot of AI-focused techbio Recursion, is teaching scientists to build companies, one founder at a time.
Kailera Therapeutics appears to have set a new benchmark for biotech IPOs with an upsized $625 million offering to fund its pipeline of obesity therapies. The Waltham, Massachusetts-headquartered ...
Eli Lilly struck a deal to acquire Kelonia Therapeutics for $3.25 billion, the companies said Monday. The deal price could reach as much as $7 billion if Kelonia reaches certain clinical, regulatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results